RaphaelE.PollockMDPhD, FACS

General Surgery • Columbus, OH

Surgical Oncology (Other than Breast)

Director of The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute

Join to view full profile

Dr. Pollock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pollock's full profile

Already have an account?

Office
460 West 10th Avenue, Suite D920
Columbus, OH 43210
Phone+1 614-293-7171

Summary

Raphael E. Pollock, MD, PhD, Dr. Pollock joined the faculty of the University of Texas MD Anderson Cancer Center in 1984 upon completion of fellowship training at that institution. In 1993 Dr. Pollock began service as Chairman of the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, a position that he held until 2010. In 1996, service as Head of the Division of Surgery at the University of Texas MD Anderson Cancer Center was begun, a position entailing supervisory relationships with all seven surgical specialty departments at that institution. In 2013 Dr. Pollock was recruited to The Ohio State University as Professor and Director of the Division of Surgical Oncology and Chief of Surgical Services at the James Comprehensive Cancer Center. This was followed by appointment in 2015 as Surgeon in Chief, the James Comprehensive Cancer Center and Surgeon in Chief, The Ohio State University Health System. In 2017, Dr. Pollock was appointed to his current position as Professor and Director, The Ohio State University Comprehensive Cancer Center.
Dr. Pollock’s clinical and laboratory research work focuses on soft tissue sarcoma, a rare tumor system of connective tissue origin.

Pollock Lab | OSUCCC - James

The Sarcoma Research Laboratory is a translational investigative environment focusing on soft tissue sarcoma and related malignancies led by Raphael Pollock, MD

Raphael Pollock | The Ohio State University Wexner Medical Center

Director, The Ohio State University Comprehensive Cancer Center Raphael Pollock is an internationally renowned cancer surgeon with more than three decades of ex

Raphael Pollock, MD, PhD- Sarcoma Cancer Treatment

Dr. Pollock has a lifetime dedication to patient care & research in soft tissue sarcoma. Learn of his association with Sarcoma Foundation of America.

Raphael E. Pollock, MD, PhD

The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA Dr. Pollock joined the faculty of the University of Texas MD Anderson Cancer C

Dr. Raphael E Pollock - Cancer Researcher at OSUCCC - James

Raphael Pollock, MD, PhD, is a practicing surgical oncologist and director of The Ohio State University Comprehensive Cancer Center (OSUCCC). He is also a membe

Dr. Raphael E Pollock

Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017 Named to the Castle Connolly list of "America's Top Doctors," 2004-

Cancer care, treatment & research experts | OSUCCC - James

Here is some information from The Ohio State University Comprehensive Cancer Center - (OSUCCC - James) I wanted to share with you.

Education & Training

University of Texas Health Science Center at HoustonPh.D., 1990
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1982 - 1984
Rush University Medical CenterResidency, Surgery, 1980 - 1982
University of ChicagoResidency, Surgery, 1977 - 1980
Saint Louis University School of MedicineClass of 1977
Oberlin CollegeBA, History, High Honors, 1972

Certifications & Licensure

OH State Medical License 2013 - 2026
TX State Medical License 1985 - 2015
IL State Medical License 1978 - 1987
American Board of Surgery Surgery
American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2020
Daniel M. Miller Distinguished Lecturer University of Nebraska, 2014
Top Doctors:SE Texas Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Outstanding Teacher Award University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, 2013
Outstanding Research Mentor Award University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, 2013
Nobility in Science Award Sarcoma Foundation of America, 2011
William D. Seybold Distinguished Lecturer Baylor College of Medicine, 2010
Honorary Member Society of Black Academic Surgeons, 2008
Annual Award Society of Surgical Oncology, 2007
Honorary Member Minneapolis Surgical Society, 2005
Honorary Member Colegio Brasileiro de Cirurgioes, 2005
Faculty Achievement Award in Education UT MD Anderson Cancer Center, 1996
Outstanding Teacher Award Department of General Surgery, UT MD Anderson Cancer Center, 1991
Faculty Excellence Award UT MD Anderson Hospital and Tumor Institute, 1985
MD Anderson Associates Award for Outstanding Accomplishment During Fellowship UT MD Anderson Hospital and Tumor Institute, 1984
First Prize Winner, Annual Clinical Training Research Project Competition UT MD Anderson Hospital and Tumor Institute, 1984
Grand Prize, Resident Research Competition Houston Surgical Society, 1984
Fellow in Clinical Oncology American Cancer Society, 1982
Recipient, Fulbright-Hays/DAAD Fellowship -- Study of Modern German History University of Marburg, 1972
Dr. Clarence Monroe Award, Grand Prize, Resident Research Competition Chicago Society for Plastic and Reconstructive Surgery
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms Start of enrollment: 2006 Nov 01
Active, not recruiting
REtroperitoneal SArcoma Registry: an International Prospective Initiative Start of enrollment: 2016 Sep 01
Recruiting

Publications & Presentations

PubMed

Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates.
Luke V Selby, Emma Clark, James L Chen, Gabriel Tinoco, Joal D Beane
Journal of Surgical Oncology. 2024-09-01
Mechanical property estimation of sarcoma-relevant extracellular vesicles using transmission electron microscopy.
Premanshu Kumar Singh, Patricia Sarchet, Catherine Hord, Lucia Casadei, Raphael Pollock
Journal of Extracellular Biology. 2024-07-01
ASO Visual Abstract: Comparing Multivisceral Resection with Tumor-Only Resection of Liposarcoma Using the Win Ratio.
Leva Gorji, Melica Nikahd, Amblessed Onuma, Diamantis Tsilimigras, J Madison Hyer
Annals of Surgical Oncology. 2024-06-01

Journal Articles

Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Alexander J Lazar, Joseph A Ludwig, Cynthia E Herzog, Raphael E Pollock, Clinical Cancer Research
Histone deacetylase inhibition for the treatment of epithelioid sarcoma; novel cross talk between epigenetic components
Song Y, Lopez G, Lam R, Ruder D, Creighton C, Bid HK, Bolshakov S, Zhang X, Lev D, Pollock RE, Mol Cancer Res, 1/1/2016
Radiation-associated undifferentiated pleomorphic sarcoma is associated with worse clinical outcomes compared to sporadic lesions
Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Al Sannaa G, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, To..., Ann Surg Onc, 1/1/2015
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma
Tseng WW, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PW, Cancer, 1/1/2015
Targeting notch pathway: a potential therapeutic approach for desmoid tumors
Shang H, Braggio D, Lee Y-J, Ingram DR, Bolshakov S, Creighton CJ, Al-Sannaa G, Lazar AJF, Lev D, Pollock RE, Cancer, 1/1/2015
Accuracy of preoperative percutaneous biospsy for the diagnosis of retroperitoneal liposarcoma subtypes
Ikoma N, Torres K, Somaiah N, Hunt K, Cormier J, Tseng W, Lev D, Pollock RE, Feig B, Ann Surg Onc, 1/1/2015
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
Bill KL, Garnett J, Ma X, Belousov R, May C, Ingram DR, Bolshakov S, Lazar AJ, Lev D, Pollock RE, Lab Invest, 1/1/2015
Angiosarcoma: a rare malignancy with protean clinical presentations
Huntington, JT, Jones CD, Liebner DA, Pollock RE, J Surg Oncol, 1/1/2015
Antitumor effects of pharmacological inhibition of EZH2 suppresses malignant peripheral nerve sheath tumor growth in vitro and in vivo through miR-30/KPNB1 pathways
Zhang P, Yang X, Ma X, Ingram DR, Lazar AJ, Torres K, Pollock RE, Mol Cancer, 1/1/2015
Management of primary retroperitoneal sarcoma (RPS) in the adult A consensus approach from the Trans-Atlantic RPS working group
Bonvalot S, Hohenberger P, Pollock RE, Premanand C, Rutkowski P, Strauss D, Swallow C, Ann Surg Onc, 1/1/2015
Contemporary approaches to sarcoma
Pollock RE, Kraybill WG, J Surg Onc, 1/1/2015
Line-scan Raman microscopy complements optical coherence tomography for tumor boundary detection
Sudheendran N, Qi J, Young ED, Lazar AJ, Lev DC, Pollock RE, Larin KV, Shih WC, Laser Phys. Lett., 1/1/2014
Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
The ESMO/European Sarcoma Network Working Group, Pollock RE, Ann Oncol, 1/1/2014
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
Hwang JA, Yang H-M, Hong D-P, Joo S-Y, Choi Y-L, Park J-H, Lazar AJ, Pollock RE, Lev D, Kim SJ, Oncotarget, 1/1/2014
Epigenetic regulators: new therapeutic targets for soft tissue sarcoma
Zhang P, Pollock RE, Cancer Cell and Microenvironment, 1/1/2014
Patient-derived xenografts for individualized care in advanced sarcoma
Stebbing J, Paz K, Schwartz G, Wexler L, Maki R, Pollock RE, Morris R, Cohen R, Shanker A, Blackman G, Harding V, Vasquez D, Krell JA, Ciznadija D, Katz A, Sidransky D, Cancer, 1/1/2014
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors
Bednarski B, Araujo D, Yi M, Torres K, Lazar A, Trent J, Cormier J, Pisters P, Lev D, Pollock RE, Feig B, Hunt K, Ann Surg Onc, 1/1/2014
Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?
Tseng W, Madewell J, Wei W, Somaiah N, Lazar A, Ghadimi M, Hoffman A, Pisters P, Lev D, Pollock RE, Ann Surg Onc, 1/1/2014
EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumor cell survival and tumorigenesis
Zhang, P, Garnett, J, Creighton, C, Al Sannaa, GA, Ingram, DR, Lazar, A, Liu, X, Liu, C, Pollock RE, J Pathol, 1/1/2014
Mesenchymal to epithelial transition in sarcomas
Yang J, Du X, Wang G, Sun Y, Chen K, Zhu X, Lazar AJ, Hunt KK, Pollock RE, Zhang W, Eur J Cancer, 1/1/2014
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation
Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock RE, Verstovsek S, Leuk Lymphoma, 1/1/2014
Three-dimensional computational analysis of optical coherence tomography imagages for detection of soft tissue sarcomas
Wang S, Liu C, Zakharov V, Lazar A, Pollock RE, Larin K, Jour Biomed Opt, 1/1/2014
Computational analysis of optical coherence tomography images for the detection of soft tissue sarcomas
Wang S, Sudheendran N, Liu C, Manapuram R, Zakharov V, Ingram D, Lazar A, Lev D, Pollock RE, Larin K, J Biomed Opt, 1/1/2013
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent multicenter validation study
Columbo C, Rosalba M, Lazar A, Perrone F, Pollock RE, Le Cesne A, Hartgrink H, Cleton-Jansen A, Domont J, Bovee J, Bonvalot S, Lev D, Gronchi A, Cancer, 1/1/2013
Complex reconstruction of desmoid tumor resections does not increase desmoid tumor recurrence
Garvey P, Booth J, Baumann D, Calhoun K, Liu J, Pollock RE, Butler C, J Am Coll Surgeons, 1/1/2013
Join now to see all

Books/Book Chapters

UICC Manual of Clinical Oncology
O’Sullivan B, Brierley J, Pollock RE, D’Cruz A, Fey M, Vermoken JWiley, Oxford, UKEdition 9th,2015
UICC Manual of Clinical Oncology
Chapter: Melanoma
O’Sullivan B, Pollock RE, Margolin KJohn Wiley and Sons, Inc, New York, NY2015
Holland-Frei Cancer Medicine
Bast RC, Croce CM, Hait WN, Hong WK, Kufe DW, Piccart-Gebart M, Pollock RE, Weichselbaum RR, Wang H, Holland JFJohn Wiley and Sons, Oxford, UKEdition 9th,2015
Principles of Surgery
Brunicardi C, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock REMcGraw-Hill Publishing, New YorkEdition 10th,2014
60 Years of Survival Outcomes at the University of Texas, MD Anderson Cancer Center
Chapter: Soft tissue sarcoma
Ravi V, Pollock RE, Patel SREditors: Burke T, Rodriguez A, and Walters R.Springer, New York, NY2013
Evidence-Based Medicine in Elective General Surgery
Chapter: Soft tissue sarcoma
Torres T, Pollock REEditors: Cohn S, Brower S.Elsevier, New York, NY2012
Oncologic Imaging
Chapter: Primary retroperitoneal tumors
Raval B, Pollock RE. Guadagnolo A, Patel SEditors: Silverman PM.Elsevier, New York, NY2012
Cancer Medicine
Hong WK, Bast R, Hait WN, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei EPeople’s Medical Publishing House-USA, Shelton, ConnecticutEdition 8th,2010
Cancer Medicine
Chapter: Principles of Surgical Oncology
Pollock RE, Morton DL, Choti MEditors: Kufe D, Pollock RE, Weichselbaum R, Bast R, Holland J, Frei III E.B.C. Decker, Ontario, CanadaEdition 8th,2010
Gene-based Therapies for Cancer
Chapter: Gene Therapy for Sarcoma
Torres KE, Pollock REEditors: Roth J.Springer, New York, NY2010
Principles of Surgery
Brunicardi C, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock REMcGraw-Hill Publishing, New YorkEdition 9th,2009
Medical Care of Cancer Patients
Chapter: Long-term consequences of cancer surgery
Bedrosian, I, Lambert, LA, Pollock REEditors: Yeung S-CJ, Escalante C, Gagel R.B.C. Decker, Ontario, Canada2009
AJCC Cancer Staging Manual
Chapter: Soft tissue sarcoma
Pollock REEditors: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M.Springer, New York, NYEdition 7th,2009
The Breast, Comprehensive Management of Benign and Malignant Disorders
Chapter: Surgical procedures for advanced local and regional malignancies of the breast
Fearmonti R, Beahm E, Hunt K, Pollock REEditors: Bland K, Copeland E.Elsevier, New York, NYEdition 4th,2009
Advanced Therapy in Surgical Oncology
Pollock RE, Curley SA, Ross MI, Perrier NDB.C. Decker, Inc, Hamilton, Ontario2007
Internal Medicine Care of Cancer Patients
Chapter: Unintended effects of cancer surgery
Bedrosian I, Lambert L, Pollock REEditors: Gagel R, Escalante C, Yeung S-C J.B.C. Decker, Ontario, Canada2007
Advanced Therapy of Surgical Oncology
Chapter: Surgical oncology in multimodality cancer care: History and Scope
Pollock REEditors: Pollock RE, Curley SA, Ross MI, Perrier ND.B.C. Decker, Ontario, Canada2007
Cancer Medicine
Kufe DW, Bast R, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei EB.C. Decker, Inc, Hamilton, OntarioEdition 7th,2006
Acute Care of the Cancer Patient
Chapter: Principles of surgical cancer care
Cormier JN, Pollock REEditors: Shaw AD, Riedel BJCJ, Burton A, Fields A, Feeley TW.Taylor and Francis Group, Boca Raton, FL2005
Principles of Surgery
Chapter: Soft tissue sarcomas
Cormier JN, Pollock REEditors: Brunicardi FC, Andersen D, Billiar T, Dunn D, Hunter J, Pollock RE.McGraw Hill Medical Publishing Inc, New York, NYEdition 8th,2004
Principles of Surgery
Chapter: Oncology
Meric-Bernstam F, Pollock REEditors: Brunicardi FC, Andersen D, Billiar T, Dunn D, Hunter J, Pollock RE.McGraw Hill Medical Publishing Inc, New York, NYEdition 8th,2004
UICC Manual of Clinical Oncology
Pollock RE, Doroshow JH, Khayat D, Nakao O, O’Sullivan, BJohn Wiley and Sons, Inc, New YorkEdition 8th,2004
Principles of Surgery
Brunicardi C, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock REMcGraw-Hill Publishing, New YorkEdition 8th,2004
The Principles and Practice of Gastrointestinal Oncology
Chapter: Epidemiology, pathology, molecular biology, and natural history of gastrointestinal sarcomas
Bilimoria M, Pollock REEditors: Abbruzzese JL, Evans D, Willet C, Hamilton S.Oxford University Press, Oxford2003
Soft Tissue Sarcomas. Surgical Oncology Clinics of North America
Pollock REW.B. Saunders Company, Philadelphia, PA2003
Join now to see all

Abstracts/Posters

Surgical stress generation of suppressor cells which impair natural killer cell cytotoxicity
Pollock RE, Lotzova E, Stanford D, Romsdahl M, American Association for Cancer Research, Houston, TX, 1/1/1985
Soft tissue sarcomas of the shoulder: factors influencing local recurrence, distant metastases, and survival
Meterissian SH, Reilly JA, Murphy A, Romsdahl MM, Pollock RE, Society Surgical Oncology, Houston, TX, 1/18/1994
Splenic natural killer cell cytotoxicity (NKCC) can be augmented in patients with leukemia
Pollock RE, Savary C, Lotzova E, American Association for Cancer Research, Washington, DC, 1/24/1990
Identification of human peripheral blood lymphocytes (PBL) responsible for long-term IL-2 dependent antitumor cytotoxicity
Fuchshuber P, Lotzova E, Pollock RE, American Association for Cancer Research, San Francisco, CA, 1/25/1989
Reversal of tumor-induced suppression of natural killer cell cytotoxicity does not prevent metastases
Ross MI, Pollock RE, American Association for Cancer Research, San Francisco, CA, 1/25/1989
Role of erythroblast in mechanism of surgical stress impairment of murine natural killer cell cytotoxicity
Pollock RE, American Association for Cancer Research, New Orleans, LA, 1/25/1988
Surgical stress impairs murine natural killer cell cytotoxicity (NKCC): multiple suppressor cells
Pollock RE, Federation of American Societies for Experimental Biology, Las Vegas, NV, 1/2./1988
Surgical stress impairs cytotoxic lysis kinetics (V Max) of murine natural killer cells
Pollock RE, 1st International Congress on the Immune Consequences of Trauma, Shock and Sepsis, Munich, Federal Republic of Germany, 1/3./1988
Recombinant IL-2 inhibits surgical-stress generated NK suppressor cells
Pollock RE, American Association for Cancer Research, Atlanta, GA, 1/22/1987
Surgical stress mediated suppression of natural killer cell cytotoxicity and metastatic enhancement
Pollock RE, Babcock G, Romsdahl M, Nishioka K, American Association for Cancer Research/The University of Texas System Cancer Center, MD Anderson Hospital and Tumor Institute Annual Clinical Training Research Project Competition, Toronto, Canada, 1984; Houston, TX, 1984, 1/8./1984
Join now to see all

Lectures

From the clinic to the corner office
Columbus, OH - 1/29/2016
New research perspectives in soft tissue sarcoma
Nationwide Children’s Hospital, Columbus, OH - 1/1./2016
Management of localized soft tissue sarcoma
Milan, Italy - 1/15/2016
Contemporary issues in retroperitoneal sarcoma
Caesarea, Israel - 1/11/2016
Building the academic surgery career
Jackson Hole, WY - 1/8./2015
Evaluation of patient-derived and long-passaged cell lines and xenografts for the study of sarcoma
Salt Lake City, UT - 1/5./2015
Targeting the notch pathway: a potential therapeutic approach for desmoid tumors
Philadelphia, PA - 1/17/2015
What your oncologic surgeon really wants to know
Columbus, OH - 1/10/2015
Contemporary issues in surgical management of gastrointestinal stromal tumors
University of Texas MD Anderson Cancer Center, Houston, TX - 1/26/2015
New approaches in retroperitoneal sarcoma
Pittsburgh, PA - 1/19/2015
Contemporary issues in soft tissue sarcoma
Chicago, IL - 1/26/2015
A surgical oncologist’s perspective on sarcoma multidisciplinary management
Columbus, OH - 1/6./2015
New horizons in sarcoma surgery
Tel Aviv, Israel - 1/21/2015
SARC Sarcoma SPORE update
Chicago, IL - 1/29/2015
Contemporary perspectives in leiomyosarcoma research
Columbus, OH - 1/24/2015
The hepatocyte growth factor receptor as a potential therapeutic target in dedifferentiated liposarcoma
Mumbai, India - 1/17/2015
Setting the stage: natural history, staging and prognostic factors
San Francisco, CA - 1/27/2014
Histone deacetylase inhibitor-based therapeutic strategy
Berlin, Germany - 1/16/2014
The hepatocyte growth factor receptor as a therapeutic target in dedifferentiated liposarcoma
Bethesda, MD - 1/6./2014
A rational search for novel anti-drug therapies
Philadelphia, PA - 1/27/2014
Emerging multidisciplinary approaches for the management of gastrointestinal stromal tumors
Newark, DE - 1/25/2014
Difficult cases in sarcoma
San Francisco, CA - 1/14/2014
Contemporary approaches to retroperitoneal sarcoma
Omaha, NE - 1/10/2014
Personalising local treatment of STS, in brief
Milan, Italy - 1/19/2014
Extended surgery for retroperitoneal liposarcoma
Milan, Italy - 1/11/2013
Join now to see all

Other

Mechanisms of Surgical Stress Impairment of Murine Natural Killer Cell Cytotoxicity
Pollock R, Ph.D. Dissertation

Press Mentions

Bridget Oppong Tapped as Deputy Director of Ohio State's Center for Cancer Health EquityNovember 30th, 2021
Ohio State Offering Additional COVID-19 Shot for Immunocompromised PeopleAugust 17th, 2021
Doubling down: Pelotonia Plans to Increase Fundraising to $50 Million Annually by 2026June 30th, 2021
Join now to see all

Grant Support

Soft Tissue Sarcoma--P53 And VEGF InductionNational Cancer Institute2000–2004
Training Of Academic Surgical OncologistsNational Cancer Institute1996–1999
Therapy And Biological Correlates Of Soft-Tissue SarcomaNational Cancer Institute1995–1998
NK Cell Genesis From Human Bone Marrow ProgenitorsNational Cancer Institute1993–1994
Surgical Stress Impairment Of Human NK Cell CytotoxicityNational Cancer Institute1990–1994
Natural Killer Cell--Toxicology Following SurgeryNational Cancer Institute1988
Chem Study Of Natl Killer Cell TOX Following Surg StressNational Cancer Institute1987
Physician-Investigator Development Award ProgramNational Cancer Institute1985–1986